393 related articles for article (PubMed ID: 31394893)
1. Diagnosis and Management of Gastric Intestinal Metaplasia: Current Status and Future Directions.
Huang RJ; Choi AY; Truong CD; Yeh MM; Hwang JH
Gut Liver; 2019 Nov; 13(6):596-603. PubMed ID: 31394893
[TBL] [Abstract][Full Text] [Related]
2. Prevalence, risk factors, and surveillance patterns for gastric intestinal metaplasia among patients undergoing upper endoscopy with biopsy.
Huang RJ; Ende AR; Singla A; Higa JT; Choi AY; Lee AB; Whang SG; Gravelle K; D'Andrea S; Bang SJ; Schmidt RA; Yeh MM; Hwang JH
Gastrointest Endosc; 2020 Jan; 91(1):70-77.e1. PubMed ID: 31425693
[TBL] [Abstract][Full Text] [Related]
3. Gastric Intestinal Metaplasia: Real Culprit or Innocent Bystander as a Precancerous Condition for Gastric Cancer?
Sugano K; Moss SF; Kuipers EJ
Gastroenterology; 2023 Dec; 165(6):1352-1366.e1. PubMed ID: 37652306
[TBL] [Abstract][Full Text] [Related]
4. Update on the Diagnosis and Management of Gastric Intestinal Metaplasia in the USA.
Trieu JA; Bilal M; Saraireh H; Wang AY
Dig Dis Sci; 2019 May; 64(5):1079-1088. PubMed ID: 30771043
[TBL] [Abstract][Full Text] [Related]
5. Low prevalence of gastric intestinal metaplasia and Helicobacter pylori on surveillance upper endoscopy in Lynch syndrome.
Pulaski M; Dungan M; Weber M; Constantino G; Katona BW
Fam Cancer; 2024 Mar; 23(1):23-27. PubMed ID: 38291131
[TBL] [Abstract][Full Text] [Related]
6. Bile reflux and bile acids in the progression of gastric intestinal metaplasia.
Qu X; Shi Y
Chin Med J (Engl); 2022 Jul; 135(14):1664-1672. PubMed ID: 35940882
[TBL] [Abstract][Full Text] [Related]
7. Gastric intestinal metaplasia - age, ethnicity and surveillance for gastric cancer.
Simko V; Anand N; Ginter E
Bratisl Lek Listy; 2015; 116(1):3-8. PubMed ID: 25666954
[TBL] [Abstract][Full Text] [Related]
8. Gastric intestinal metaplasia: when to treat? How to treat?
Abdelfattah T; Shahab O; Shah TU
Curr Opin Gastroenterol; 2021 Nov; 37(6):602-608. PubMed ID: 34432654
[TBL] [Abstract][Full Text] [Related]
9. Effect of eradication of Helicobacter pylori on the histology and cellular phenotype of gastric intestinal metaplasia.
Watari J; Das KK; Amenta PS; Tanabe H; Tanaka A; Geng X; Lin JJ; Kohgo Y; Das KM
Clin Gastroenterol Hepatol; 2008 Apr; 6(4):409-17. PubMed ID: 18321787
[TBL] [Abstract][Full Text] [Related]
10. Risk of Gastric Cancer Among Patients With Intestinal Metaplasia of the Stomach in a US Integrated Health Care System.
Reddy KM; Chang JI; Shi JM; Wu BU
Clin Gastroenterol Hepatol; 2016 Oct; 14(10):1420-5. PubMed ID: 27317852
[TBL] [Abstract][Full Text] [Related]
11. Risk of Progression of Gastric Intestinal Metaplasia Is Significantly Greater When Detected in Both Antrum and Body.
O'Connor A; Bowden A; Farrell E; Weininger J; Crowther S; McNamara D; Ridgway P; O'Morain C
Dig Dis Sci; 2021 Oct; 66(10):3470-3475. PubMed ID: 33094451
[TBL] [Abstract][Full Text] [Related]
12. Helicobacter pylori associated gastric intestinal metaplasia: Treatment and surveillance.
Liu KS; Wong IO; Leung WK
World J Gastroenterol; 2016 Jan; 22(3):1311-20. PubMed ID: 26811668
[TBL] [Abstract][Full Text] [Related]
13. Gastric Intestinal Metaplasia in Mucosa Adjacent to Gastric Cancers Is Rarely Associated With the Aneuploidy That Is Characteristic of Gastric Dysplasia or Cancer.
Zhang R; Rabinovitch PS; Mattis AN; Lauwers GY; Choi WT
Am J Surg Pathol; 2021 Oct; 45(10):1374-1381. PubMed ID: 34091484
[TBL] [Abstract][Full Text] [Related]
14. Magnifying endoscopy with narrow-band imaging for diagnosis of subtype of gastric intestinal metaplasia.
Kanemitsu T; Uedo N; Ono T; Nimura S; Hasegawa R; Imamura K; Ohtsu K; Ono Y; Miyaoka M; Ueki T; Tanabe H; Ohta A; Iwashita A; Yao K
J Gastroenterol Hepatol; 2023 Jan; 38(1):94-102. PubMed ID: 36268636
[TBL] [Abstract][Full Text] [Related]
15. Risk Score Using Demographic and Clinical Risk Factors Predicts Gastric Intestinal Metaplasia Risk in a U.S. Population.
Tan MC; Ho Q; Nguyen TH; Liu Y; El-Serag HB; Thrift AP
Dig Dis Sci; 2022 Sep; 67(9):4500-4508. PubMed ID: 34797447
[TBL] [Abstract][Full Text] [Related]
16. Identifying high-risk individuals for gastric cancer surveillance from western and eastern perspectives: Lessons to learn and possibility to develop an integrated approach for daily practice.
Quach DT; Hiyama T; Gotoda T
World J Gastroenterol; 2019 Jul; 25(27):3546-3562. PubMed ID: 31367156
[TBL] [Abstract][Full Text] [Related]
17. The detection, surveillance and treatment of premalignant gastric lesions related to Helicobacter pylori infection.
de Vries AC; Haringsma J; Kuipers EJ
Helicobacter; 2007 Feb; 12(1):1-15. PubMed ID: 17241295
[TBL] [Abstract][Full Text] [Related]
18. Lack of clinical usefulness of Das-1 monoclonal antibody and mucin expression as risk markers of gastric carcinoma in patients with gastric intestinal metaplasia.
Forné M; Fernández-Bañares F; González-Mínguez C; Casalots J; Poblet-Mas N; Garcia-Gil LJ; Esteve M; Rosinach M; Espinós J; Loras C; Salas A; Viver JM
Am J Clin Pathol; 2009 Jan; 131(1):99-105. PubMed ID: 19095572
[TBL] [Abstract][Full Text] [Related]
19. Preferential expression of cyclooxygenase-2 in colonic-phenotype of gastric intestinal metaplasia: association with helicobacter pylori and gastric carcinoma.
Sun JH; Das KK; Amenta PS; Yokota K; Watari J; Sato T; Kohgo Y; Das KM
J Clin Gastroenterol; 2006 Feb; 40(2):122-8. PubMed ID: 16394872
[TBL] [Abstract][Full Text] [Related]
20. How Do We Manage Gastric Intestinal Metaplasia? A Survey of Clinical Practice Trends for Gastrointestinal Endoscopists in the United States.
Vance RB; Kubiliun N; Dunbar KB
Dig Dis Sci; 2016 Jul; 61(7):1870-8. PubMed ID: 26984230
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
